Company profile
Nautilus Biotechnology, Inc. Insider Trading
NAUTEvery SEC Form 4 insider trading filing for Nautilus Biotechnology, Inc. (NAUT) since April 2023 — open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC. Why 2023?
- Exchange
- Nasdaq
- Sector
- Laboratory Analytical Instruments
- CIK
- 0001808805
- Filings
- 62
- Insiders
- 25
- Last filing
- 2026-06-18
Activity summary
No insider transactions in the last 30 days. The most recent was on June 18, 2026, when Karen Akinsanya bought 45,000 shares. 62 filings from 25 insiders are on record below.
Three year balance
Buy and sell value by quarter, Q3 23 to Q2 26. Nautilus Biotechnology, Inc. insiders are net sellers across the period shown.
Bars below the rule are sales, above are purchases. Largest quarter on the chart is $11.8M.
No insider activity recorded for NAUT in the last 90 days.
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 18, 2026 | Karen Akinsanya | NAUT | Award | 45,000 | — | — |
| Jun 18, 2026 | Farzad Nazem | NAUT | Award | 45,000 | — | — |
| Jun 18, 2026 | Matthew L. Posard | NAUT | Award | 45,000 | — | — |
| Jun 18, 2026 | Epperly Melissa B, | NAUT | Award | 45,000 | — | — |
| Jun 18, 2026 | Matthew S McIlwain | NAUT | Award | 45,000 | — | — |
45 more transactions hidden
Free account · No credit card required
Building something? Get API access →
Query this yourself
The same rows, over the API.
curl "https://api.form4api.com/v1/transactions?ticker=NAUT" \
-H "X-Api-Key: $KEY"Top insiders
By total value filed.
Institutional Ownership
Top 13F-HR holders of Nautilus Biotechnology, Inc. as of 2026-06-30
Data source: quarterly 13F-HR filings — institutional holders report positions within 45 days of quarter end. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →